UK court upholds Teva’s patent on Copaxone

[MSUK]

Teva received good news this week with the decision by a UK court to uphold the company's patent for multiple scleroris (MS) treatment Copaxone.

The Court of Appeal for England and Wales agreed with an earlier decision by the UK's High Court to defend the patent for Copaxone (glatiramer acetate injection) after its validity was challenged by Mylan..... Read More - http://www.ms-uk.org/index.cfm/copaxone